BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/1/2023 1:04:32 PM | Browse: 488 | Download: 1247
 |
Received |
|
2022-12-29 22:17 |
 |
Peer-Review Started |
|
2022-12-29 22:19 |
 |
First Decision by Editorial Office Director |
|
2023-02-15 06:51 |
 |
Return for Revision |
|
2023-02-15 06:51 |
 |
Revised |
|
2023-02-25 17:20 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2023-04-28 03:33 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2023-04-28 17:43 |
 |
Articles in Press |
|
2023-04-28 17:43 |
 |
Edit the Manuscript by Language Editor |
|
2023-05-03 21:41 |
 |
Typeset the Manuscript |
|
2023-05-24 10:09 |
 |
Publish the Manuscript Online |
|
2023-06-01 13:04 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Gowthami Sai Kogilathota Jagirdhar, Rakhtan K Qasba, Harsha Pattnaik, Kaanthi Rama, Akshat Banga, Shiva Teja Reddy, Anna Carolina Flumignan Bucharles, Rahul Kashyap, Praveen Reddy Elmati, Vikas Bansal, Yatinder Bains, Theodore DaCosta and Salim Surani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salim Surani, FCCP, MD, MHSc, Professor, Department of Medicine, Texas A&M University, Administration Building, 400 Bizzell St, College Station, TX 77843, United States. srsurani@hotmail.com |
| Key Words |
Non-alcoholic fatty liver; Fatty liver; Coronavirus; COVID-19; Metabolic associated fatty liver |
| Core Tip |
Metabolic-associated fatty liver disease (MAFLD) is like non-alcoholic fatty liver disease (NAFLD) and is a hepatic presentation of metabolic syndrome. NAFLD and MAFLD and widely prevalent. It is estimated that 25% of the United States population have this condition. The association and effect size between fatty liver disease and coronavirus disease 2019 (COVID-19) infection is still unconfirmed. The discrepancies in the available literature may be due to study design, confounding, small study population, and heterogeneity. We performed a systematic review and meta-analysis to study the impact of NAFLD/MAFLD on mortality, hospitalization, hospital length of stay, and supplemental oxygen utilization in COVID-19 patients. |
| Publish Date |
2023-06-01 13:04 |
| Citation |
Jagirdhar GSK, Qasba RK, Pattnaik H, Rama K, Banga A, Reddy ST, Flumignan Bucharles AC, Kashyap R, Elmati PR, Bansal V, Bains Y, DaCosta T, Surani S. Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis. World J Gastroenterol 2023; 29(21): 3362-3378
|
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i21/3362.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i21.3362 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.